研究单位：[1]The First Hospital of Shijiazhuang[2]Peking University People's Hospital[3]Peking University People's Hospital,Beijing,Beijing,China,100044[4]Affiliated Hospital of Hebei University,Baoding,Hebei,China,071000[5]Hebei Medical University Fourth Hospital,Shijiazhuang,Hebei,China,050011[6]The First Hospital of Shijiazhuang,Shijiazhuang,Hebei,China,050011[7]Xingtai People's Hospital,Xingtai,Hebei,China,054031[8]Handan Downtown Hospital,Handan,Heibe,China,056001[9]Tianjin Medical University Cancer Institute and Hospital,Tianjin,Tianjin,China,300000[10]Tianjin Medical University General Hospital,Tianjin,Tianjin,China,300052
Conduct a prospective study in multicenter to confirm the value of circulating tumor DNA in longitudinal monitoring of stage III-IV lung cancer patients.
